Melbourne Renal Research Group

Melbourne Renal Research Group (MRRG) is a specialized clinical research organization and trial site based in Melbourne, Australia, dedicated to the field of nephrology. Led by Associate Professor David Packham, the group has over 30 years of experience in the design and execution of Phase 1 through Phase 4 clinical trials for global pharmaceutical and biotechnology sponsors. MRRG focuses on advancing therapies for chronic kidney disease (CKD), IgA nephropathy, and rare renal conditions like focal segmental glomerulosclerosis (FSGS). The group is recognized as a leading recruitment center in the Asia-Pacific region and maintains strong academic and clinical ties with the University of Melbourne and the Royal Melbourne Hospital. Their expertise encompasses a wide range of therapeutic modalities, including small molecules, monoclonal antibodies, and regenerative cell therapies.